BacLite Rapid MRSA Clinical Performance

Methicillin Resistance Clinical Trial

Official title:

BacLite Rapid MRSA Clinical Performance

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT00541632
• Other study ID #: 010737
• Status: Terminated
• Phase: N/A
• First received: October 6, 2007
• Last updated: May 14, 2008
• Start date: October 2007
• Est. completion date: March 2008

Study information

• Verified date: May 2008
• Source: 3M
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to compare the performance of the 3M(TM) BacLite (TM) Rapid MRSA test system to traditional culture methods in detecting the presence of Methicillin Resistant Staphylococcus aureus (MRSA) directly from nasal samples.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 0
• Est. completion date: March 2008
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Subjects 18 years or older

• Subjects willing to document demographic characteristics

• Subjects willing to have their nose swabbed

• Subjects (or legal representative) willing to sign consent and authorization forms

Exclusion Criteria:

• Subjects who use Vicks Sinex Nasal spray or other nasal sprays

• Subjects with prescribed nasal medical devices where collecting samples may resent more than minimal risk to subjects

• Subjects having nasal prosthetics, jewelry or trauma to the nose or anything that may prevents sampling the anterior nares

• Investigator believes that subject is unsuitable for inclusion.

Study Design

Time Perspective: Prospective

Related Conditions & MeSH terms

• Methicillin Resistance

Locations

Country	Name	City	State
United States	Atlanta Institute for Medical Research, Inc.	Atlanta	Georgia
United States	University of Maryland	Baltimore	Maryland
United States	Cleveland Clinic	Cleveland	Ohio
United States	Denver Health Medical Center	Denver	Colorado
United States	Wayne State University	Detroit	Michigan
United States	Evanston Northwestern Healthcare	Evanston	Illinois
United States	University of Iowa	Iowa City	Iowa
United States	Washington University	St. Louis	Missouri
United States	Wake Forest University	Winston-Salem	North Carolina

Sponsors (1)

Lead Sponsor	Collaborator
3M

Country where clinical trial is conducted

United States,